INTERPRETIVE CRITERIA FOR CI-960 (AM-1091, PD127391) DISK DIFFUSION TESTS USING 5-MU-G DISKS

被引:8
作者
JONES, RN
ERWIN, ME
BARRETT, MS
机构
[1] UNIV IOWA,COLL MED,ANTI INFECT RES CTR,DEPT PATHOL,IOWA CITY,IA 52242
[2] DEPT VET AFFAIRS MED COLL,DEPT PATHOL,IOWA CITY,IA
关键词
D O I
10.1016/0732-8893(92)90029-S
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
CI-960, a new potent fluoroquinolone, was evaluated to develop disk diffusion susceptibility criteria for a 5-mu-g content disk. Preliminary interpretive zone diameter criteria were proposed for two possible susceptible breakpoint MICs (less-than-or-equal-to 1 and less-than-or-equal-to 2-mu-g/ml). Both sets of interpretive criteria performed well having 96.8%-98.4% absolute agreement and no false-susceptible errors. The more conservative less-than-or-equal-to 1-mu-g/ml breakpoint criteria had correlate zones of greater-than-or-equal-to 23 mm for susceptible and less-than-or-equal-to 19 mm for resistant. These criteria produced no false resistance, whereas 0.7% of strains exhibited major errors at the less-than-or-equal-to 2-mu-g/ml breakpoint.
引用
收藏
页码:379 / 381
页数:3
相关论文
共 10 条
[1]   ANTIMICROBIAL ACTIVITY EVALUATIONS OF 2 NEW QUINOLONES, PD127391 (CI-960 AND AM-1091) AND PD131628 [J].
BARRETT, MS ;
JONES, RN ;
ERWIN, ME ;
JOHNSON, DM ;
BRIGGS, BM .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1991, 14 (05) :389-401
[2]   ANTISTAPHYLOCOCCAL ACTIVITY OF THE FLUOROQUINOLONES CI-960, PD-131628, SPARFLOXACIN, OFLOXACIN AND CIPROFLOXACIN [J].
BARRY, AL ;
FUCHS, PC .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (03) :168-171
[3]   INVITRO ANTIBACTERIAL ACTIVITIES OF THE FLUOROQUINOLONES PD-117596, PD-124816, AND PD-127391 [J].
COHEN, MA ;
HUBAND, MD ;
MAILLOUX, GB ;
YODER, SL ;
ROLAND, GE ;
HEIFETZ, CL .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1991, 14 (03) :245-258
[4]   MULTICENTER EVALUATION OF THE INVITRO ACTIVITIES OF 3 NEW QUINOLONES, SPARFLOXACIN, CI-960, AND PD-131,628, COMPARED WITH THE ACTIVITY OF CIPROFLOXACIN AGAINST 5,252 CLINICAL BACTERIAL ISOLATES [J].
FUCHS, PC ;
BARRY, AL ;
PFALLER, MA ;
ALLEN, SD ;
GERLACH, EH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (04) :764-766
[5]   THE INVITRO ACTIVITY OF PD127,391, A NEW QUINOLONE [J].
KING, A ;
BOOTHMAN, C ;
PHILLIPS, I .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 22 (02) :135-141
[6]   COMPARATIVE INVITRO ACTIVITY OF A NEW QUINOLONE, AM-1091 [J].
NEU, HC ;
NOVELLI, A ;
CHIN, NX .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (07) :1036-1041
[7]   COMPARATIVE INVITRO ACTIVITY OF PD-127391, A NEW FLUORINATED 4-QUINOLONE DERIVATIVE [J].
NORRBY, SR ;
JONSSON, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (08) :1278-1281
[8]   INVITRO ACTIVITY OF PD-127391, AN ENHANCED-SPECTRUM QUINOLONE [J].
WISE, R ;
ASHBY, JP ;
ANDREWS, JM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (08) :1251-1256
[9]  
1990, APPROVED STANDARD M2
[10]  
1990, APPROVED STANDARD M7